We examined the effect of tamoxifen (Tmx), verapamil, and daunorubicin (DNR) in two cell lines that displayed the multidrug-resistant (MDR) phenotype and used laser flow cytometry to quantitate intracellular DNR content. In the vinblastine-resistant human lymphoblastic lymphoma cell line CEM-VBL, simultaneous incubation of DNR with Tmx 10 pmol/L or Tmx 50 pmol/L increased intracellular DNR fluorescence in a dose-dependent manner and demonstrated an uptake pattern similar to that seen with DNR Such studies have formed the rationale for phase I trials combining verapamil with vinblastine,' adriamycin," or combinations" in patients with relapsed cancer. However, one major difficulty with the use of verapamil in vivo is its extremely narrow therapeutic index; doses that approach the in vitro levels required for reversal of the MDR phenotype frequently cause significant degrees of heart block and hypotension.'-'' dipyrid a m~l e , '~. '~ reserpine,16 the calmodulin antagonist trifluoperazine,"~" and certain hormone^,''^'^ can also reverse the MDR phenotype in vitro. In this study, we examined the effect of the synthetic antiestrogen tamoxifen (Tmx) in combination with daunorubicin (DNR) in two human MDR leukemia cell lines. The lymphoblastic leukemia cell line CEM" and its vinblastine-resistant subline CEM-VBL," along with the myeloid leukemia cell line HL-6OZ3 and its vincristine-resistant subline HL-60/RV+'4 were used in these studies. We first demonstrated that each MDR subline expressed PGP by flow cytometric analysis with the murine monoclonal antibody (MoAb) HYB-241, which recognizes an external portion of the PGP molecule." We then performed (1) DNR uptake and retention studies using laser flow cytometry to quantitate intracellular DNR content26327 and (2) clonogenic assays to determine whether Tmx was by itself toxic to these cells or whether it potentiated the effect of DNR in vitro.
D major problem in oncology. One type of resistance, multidrug resistance (MDR), can develop after exposure to certain natural chemotherapeutic agents such as vinca alkaloids, anthracyclines, dactinomycin, and epipodophyllotoxins.' Cells that display the MDR phenotype demonstrate decreased intracellular drug acc~mulation'-~ because of an -170,000-d plasma membrane-associated glycoprotein (P-
glycoprotein [PGP]) that functions as an active efflux
Membrane transport studies have demonstrated that calcium channel-blocking drugs such as verapamil bind directly to PGP, allowing for increased intracellular drug Such studies have formed the rationale for phase I trials combining verapamil with vinblastine,' adriamycin," or combinations" in patients with relapsed cancer. However, one major difficulty with the use of verapamil in vivo is its extremely narrow therapeutic index; doses that approach the in vitro levels required for reversal of the MDR phenotype frequently cause significant degrees of heart block and hypotension.'-'' dipyrid a m~l e , '~. '~ reserpine,16 the calmodulin antagonist trifluoperazine,"~" and certain hormone^,''^'^ can also reverse the MDR phenotype in vitro. In this study, we examined the effect of the synthetic antiestrogen tamoxifen (Tmx) in combination with daunorubicin (DNR) in two human MDR leukemia cell lines. The lymphoblastic leukemia cell Other types of drugs, such as cyclosporin line CEM" and its vinblastine-resistant subline CEM-VBL," along with the myeloid leukemia cell line HL-6OZ3 and its vincristine-resistant subline HL-60/RV+'4 were used in these studies. We first demonstrated that each MDR subline expressed PGP by flow cytometric analysis with the murine monoclonal antibody (MoAb) HYB-241, which recognizes an external portion of the PGP molecule." We then performed (1) DNR uptake and retention studies using laser flow cytometry to quantitate intracellular DNR content26327 and (2) clonogenic assays to determine whether Tmx was by itself toxic to these cells or whether it potentiated the effect of DNR in vitro. Results of these experiments demonstrate that Tmx, in doses that may be achievable in vivo, can increase intracellular DNR concentration in MDR cells. Moreover, Tmx at low doses is not cytotoxic but strongly potentiates DNR cytotoxicity.
MATERIALS AND METHODS

Cell lines.
The parent cell lines HL-60 and CEM were obtained from the American Type Culture Collection (Rockville, MD). The HL-60 vincristine-resistant cell line (HL-60/RV+) was kindly provided by Dr Melvin S. Center (Kansas State University, Manhattan, KS). The CEM vinblastine-resistant subline was originally provided by Beck et al?* All cells were kept in RPMI 1640 (GIBCO Laboratories, Grand Island, NY) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (FCS; Hyclone, Salt Lake City, Utah) and 1% L-glutamine (GIBCO) and incubated at 37°C with 5% CO, and 95% humidified air.
Tmx citrate was kindly provided by IC1 Pharmaceuticals (Wilmington, Delaware) and dissolved in dimethyl sulfoxide (DMSO). The final concentration of DMSO in the Tmx suspension was 0.1%. Daunorubicin was purchased from Adria Laboratories (Dublin, OH), dissolved in sterile water, and diluted with RPMI containing 10% FCS before each experiment. Verapamil was obtained from Knoll Pharmaceuticals (Whippany, NJ) and dissolved in sterile NaCl with 1.57% DMSO before each experiment. The final concentration of DMSO in the verapamil suspension was 0.008% in each experiment. Solutions containing verapamil were protected from light at all times by tin foil wrapping.
For determination of flow cytometric intracellular DNR concentrations, a FACScan (Becton Dickinson, Mountain View, CA) equipped with an argon ion laser using a 488-nm line operating at 15 mW was used. Light was collected through a 585142-nm filter for the DNR uptake and retention studies.
Cells incubated at a concentra-
Drugs.
Flow cytometry.
Cell uptake and retention studies. Drug retention studies were performed in separate experiments. Cells were first incubated with either DNR 1 pg/mL or the combination of DNR and the test drug for 1 hour. All samples were then washed twice in ice-cold medium and resuspended at 37°C in fresh medium containing the specific parameter, and DNR fluorescence was measured at time 0,5,15,30,60, and 120 minutes. DNR fluorescence was measured using the same FACScan instrument as in the uptake experiments.
All drug uptake and retention experiments were performed in duplicate.
Clonogenic assays. Cells at a concentration of 2 x lo6 were incubated with either medium, 0.1% DMSO, DNR 1 pg/mL, Tmx 10 pmol/L, Tmx 50 pmol/L, or the combination of DNR 1 pg/mL plus Tmx 10 pmol/L or Tmx 50 pmoVL for 1 hour. Aliquots of these test samples were then washed twice and plated in triplicate at a concentration of 250 cells per plate. To determine whether a more prolonged exposure to Tmx had an enhanced effect on cytotoxicity, separate aliquots were simultaneously resuspended in either medium, 0.1% DMSO, DNR 1 &mL, Tmx 10 pmol/L, or Tmx 50 pmol/L for an additional 2 hours, washed twice, and plated in triplicate at the above concentration.
The effect of verapamil on clonogenic capacity was also examined. Cells were incubated with either medium, DNR 1 pg/mL, verapamil 10 pmol/L, or the combination of DNR 1 &mL plus verapamil 10 pmol/L for 1 hour. Aliquots were then washed twice and plated in triplicate at the above concentration. Separate aliquots were simultaneously resuspended in either medium, DNR 1 pg/mL, or verapamil 10 pmol/L for an additional 2 hours, washed twice, and plated in triplicate at the above concentration.
Culture medium used for plating consisted of 1 mL of Iscove's modified Dulbecco's medium (IMDM; GIBCO) containing 24% FCS, 0.8% deionized bovine serum albumin (BSA; Sigma Chemicals, St Louis, MO), mol/L 2-mercaptoethanol (Sigma), and methylcellulose at a final concentration of 1.3% in 35" Lux tissue culture dishes (Miles Scientific, Naperville, IL). Culture plates were incubated in a humidified atmosphere of 5% CO, in air for 10 to 12 days and scored using an inverted microscope. Aggregates 2 40 cells were considered colonies.
Controls for each experiment were as follows: medium alone served as controls for experiments using DNR, medium with 0.1% DMSO served as controls for experiments using Tmx, and medium with 0.008% DMSO served as controls for experiments using verapamil.
Samples of cells to be studied for PGP expression were suspended at a concentration of 1 X lo6 in 0.5 mL PBS. Two microliters of the MoAb HYB-241 (kindly provided by Dr L. Rittmann-Grauer, Hybritech Corp, San Diego, CA) was added to the test sample and 2 pg of the isotypic control antibody anti-gardenella GDJ352 (Hybritech) was added to the control sample. Both samples were processed simultaneously. The cells were first incubated on ice for 1 hour and then washed in PBS. Fifty microliters of a 1:64 dilution of ice-cold fluorescein isothiocyanate (FITC) conjugated goat antimouse IgG (Sigma) was then added and incubated for 1 hour on ice. Samples were then washed three times in PBS and fluorescence was measured immediately on the FACScan. Consort 30 and Lysis software (Becton Dickinson, San Jose, CA) was used for data analysis.
Estrogen and proQuantitation of membrane binding with HYB-241.
Estrogen and progesterone receptor analysis.
gesterone receptor analysis was performed using the dextrancoated charcoal assay?8 Figure 1A shows that the CEM-VBL cells incubated with MoAb HYB-241 strongly fluoresce, indicating the presence of PGP. Background fluorescence was determined by incubation with the control MoAb (GDJ352). No PGP-related fluorescence was detected in the parent cell line CEM. Figure To determine whether continuous exposure to verapamil or Tmx was important to maintain increased intracellular levels of DNR, a second set of samples was analyzed after resuspension in fresh medium containing the same concentration of drug that was used for the initial 1 hour of incubation; eg, cells that were incubated for 1 hour with DNR plus Tmx 10 pmoVL were washed twice and resuspended in fresh medium containing Tmx 10 pmol/L. Retention was measured at specific time points and results from these experiments are also shown in Fig 3A. Cells that were exposed to DNR and Tmx 10 pmoVL and resuspended for 2 hours in Tmx 10 FmoVL had DNR retention similar to that of cells exposed to Tmx 50 pmol/L for 1 hour and resuspended in medium. Cells exposed to DNR and verapamil and resuspended in verapamil retained a high intracellular DNR content as shown.
RESULTS
HYB-241 binding to HL-6OIRV+ and CEM-VBL cells.
CEM-VBL cells that had been incubated with DNR plus Tmx 50 pmol/L and then resuspended in medium containing Tmx 50 pmol/L demonstrated the highest intracellular concentration of DNR. As shown in Fig 3A, intracellular DNR concentration was nearly 10 times that of cells resuspended in medium alone.
Effect of T m on DNR uptake and retention in HL-6O/RV+ cells. DNR uptake studies with Tmx and verapamil were also performed using HLdO/RV+ cells. Figure 2B shows that cells incubated for 1 hour with DNR and Tmx had increased intracellular DNR levels compared with cells incubated with DNR alone. Cellular uptake appeared dose-dependent with Tmx 50 pmol/L demonstrating the highest accumulation.
DNR retention experiments were also performed after 1 hour of exposure to DNR alone, DNR with Tmx, or DNR with verapamil. Cells were then resuspended in either fresh Effect of Tmx and verapamil on clonogenic capacity of CEM-VBL and HL-6O/RV+ cells. Clonogenic assays were then performed to determine the relationship between DNR retention and cell kill. The first set of experiments was performed after 60 minutes of incubation with DNR and the drug under study. To determine whether prolonged exposure to the drug resulted in increased cell kill over that observed when cells were resuspended in fresh medium alone, a second set of clonogenic experiments was performed after an additional 2 hours of resuspension in either drug or fresh medium. Figure 5A outlines the effect of Tmx on the clonogenic l l r::: Growth inhibition after exposure to verapamil alone and in combination with DNR was also examined in CEM-VBL cells after 1 hour of exposure (Fig 5A, panels 5 
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after 2 hours of resuspension in either medium alone (panel 15) or medium containingverapamil (panel 16). Results are similar to those seen with Tmx 10 kmol/L the combination of DNR and verapamil was much more inhibitory to cell growth than either drug alone (panels 21 and 22). A similar effect was noted in HL-60/RV+ cells (Fig 5B, panels 5 and 8 after 1 hour of incubation and panels 15, 16, 21, and 22 after 2 hours of resuspension).
Estrogen and progesterone receptor analysis of CEM-B L and HL-6O/RV+ Cells. To determine whether the toxicity of Tmx correlated with expression of either estrogen or progesterone receptors on the cells, receptor analysis was performed. CEM cells had no detectable estrogen or progesterone receptors. CEM-VBL cells had no detectable estrogen receptor but were positive for the progesterone receptor (9.5 fentomole [fm]/mg protein). The HL-60 parent line and the HLdO/RV+ line were negative for both estrogen and progesterone receptors.
DISCUSSION
In this report we demonstrate that Tmx can increase DNR uptake and retention in two human leukemia cell lines that display the MDR phenotype. The increase in DNR uptake with Tmx was concentration dependent in both the CEM-VBL cells (Fig 2A) and the HLdO/RV+ cells (Fig 2B) and is unrelated to Tmx's known antiestrogenic properties because estrogen receptors were absent from both cell lines studied. Tmx had no effect on DNR uptake in the drug sensitive parent cell lines (Figs 4A  and B) .
Ramu et a1 first recognized that Tmx was able to reverse drug resistance in a murine leukemia cell line in 198419 and postulated that, by virtue of its structure, the hormone interacted with the membrane phospholipid domain in such a manner as to alter the lipid packing density and thereby the diffusion rate of certain drugs.29 However, the exact nature of its interaction with the cellular membrane has not been clarified. Clarke et alM have suggested that the plasticity of the membrane and, secondarily, its transport systems may be affected by highly lipophilic hormones. This group measured fluorescence of the fluorophore 1,6-diphenylhexatriene in the human breast cancer cells lines MCF-7 (estrogen receptor positive) and MDA-MB-436 (estrogen receptor negative) and demonstrated that both estrogen and Tmx can significantly decrease the fluidity of the cellular membranes.= Clarke et a13' have also suggested that these membrane changes account for their own previous observation concerning the dose-dependent reduction of the cytotoxic effects of methotrexate when 17b-estradiol is added to MDA-MB-436 cells'* and for the decrease in cytotoxicity induced by melphalan or fluorouracil when Tmx is added to both the estrogen receptor positive and negative breast cancer cell lines recently described by Osborne et al.33 More recent evidence suggests that Tmx interacts with specific enzyme and calcium transport systems. For example, it has been shown that Tmx antagonizes phospholipid and calmodulin-activated protein kinase C. 34 That Tmx may also bind to PGP rather than exert a more generalized effect on membrane function is suggested by the results of the experiments presented here. If Tmx altered membrane permeability such that DNR diffused in more rapidly, then intracellular DNR retention would not be expected to remain constant over time as, presumably, efflux would be just as rapid. However, the retention experiments in both the CEM-VBL (Fig 3A) and the HLdO/RV+ (Fig 3B) cell show that intracellular DNR concentrations remain relatively constant over time, suggesting that active efflux of the drug is blocked. Photoaffinity labeling studies are planned that will hopefully determine whether Tmx binds directly to PGP.
Data from the clonogenic experiments with both CEM-VBL (Fig 5A) and HL-60/RV+ cells (Fig 5B) demonstrate that Tmx 10 kmol/L had little inhibitory effect on cell growth. As expected in these drug resistant cell lines, DNR alone did not have a significant inhibitory effect on cell growth. However, incubating cells for 1 hour with the combination of Tmx 10 pmol/L and DNR resulted in a marked enhancement in cytotoxicity compared with cells exposed to DNR alone. When cells were subsequently resuspended in fresh medium containing Tmx 10 pmol/L, inhibition of cell growth increased further. This result would suggest that continued exposure to Tmx results in a higher percentage of cell death. The effect of verapamil on growth inhibition is shown in Figs 5A and B. Similar to Tmx 10 kmol/L, the inhibitory effect of incubating cells with verapamil and DNR is increased compared with incubating cells in DNR alone.
Based on the in vitro data presented here we suggest a potential new role for Tmx in patients with relapsed or refractory leukemia (or any solid tumor that demonstrates the MDR phenotype) whereby the hormone is given in high doses for a short period of time, followed by administration of a drug affected by the PGP pump such as DNR. However, we recognize that significant difficulty may exist in applying these results directly to the clinical setting. First, not all patients with relapsed or refractory disease have PGP expressed on their cells384o and overexpression of PGP may be heterogeneous within a given population of cells." It is clear that further data regarding PGP expression is needed before defining the extent of this form of drug resistance and it will be extremely important to correlate PGP expression with clinical resistance.
Second, results with the two cell lines tested here suggest that a high concentration of Tmx, in the range of 10 p,mol/L, is effective in increasing the intracellular concentration of 
